Provided by Tiger Fintech (Singapore) Pte. Ltd.

Solventum

73.97
-1.0200-1.36%
Post-market: 73.92-0.0452-0.06%18:13 EDT
Volume:1.92M
Turnover:141.89M
Market Cap:12.80B
PE:26.80
High:74.90
Open:74.55
Low:72.57
Close:74.99
Loading ...

Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment

PR Newswire
·
14 Nov 2024

Nelson Peltz Exits Disney, Shakes Up Portfolio in Q3 2024

GuruFocus.com
·
14 Nov 2024

BRIEF-Trian Fund Management, L.P. Dissolves Share Stake In Rentokil Initial, Cuts In Allstate

Reuters
·
14 Nov 2024

Trian Fund Management, L.p. Raises Share Stake in Solventum Corporation by 32.9% to 7.1 Mln Shares

THOMSON REUTERS
·
14 Nov 2024

Solventum Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
11 Nov 2024

Solventum price target raised to $73 from $60 at Morgan Stanley

TIPRANKS
·
11 Nov 2024

Solventum Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
10 Nov 2024

Assessing MedTech impact from potential China tariffs

seekingalpha
·
10 Nov 2024

Solventum Corp reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
09 Nov 2024

Solventum price target raised to $75 from $71 at Piper Sandler

TIPRANKS
·
08 Nov 2024

Travis Steed Maintains Hold Rating on Solventum Corporation Amid Uncertainties and Potential Volatility

TIPRANKS
·
08 Nov 2024

Solventum Corp (SOLV) Q3 2024 Earnings Call Highlights: Strategic Growth Amidst Market Challenges

GuruFocus
·
08 Nov 2024

Solventum Q3 Non-GAAP Earnings Fall, Sales Rise; 2025 EPS Guidance Boosted

MT Newswires Live
·
08 Nov 2024

Solventum raises annual profit forecast on strong surgical product sales

Reuters
·
08 Nov 2024

Solventum Q3 2024 Adj EPS $1.64 Beats $1.39 Estimate, Sales $2.08B Beat $2.06B Estimate

Benzinga
·
08 Nov 2024

Solventum Corp- Outlook FY Organic Sales Growth to Upper Half of 0% to +1.0% (Previously 0% to +1.0%)

THOMSON REUTERS
·
08 Nov 2024